Trials / Withdrawn
WithdrawnNCT05183880
Bioavailability of Orally Ingested Vitamin C
Investigating the Oral Bioavailability of Vitamin C Administered Using Phosphycell™ Technology - a Phosphatidylcholine-lipid Encapsulation Technology.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Exeter · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if crystalline vitamin C supplementation can acutely increase skeletal muscle vitamin C concentrations and if this can be potentiated by administering vitamin C using Phosphycell™ Technology - a phosphatidylcholine-lipid encapsulation technology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Phosphatidylcholine-lipid encapsulated vitamin C | Ingesting 1000 mg of vitamin C in phosphatidylcholine-lipid encapsulated form |
| DIETARY_SUPPLEMENT | Crystalline vitamin C | Ingesting 1000 mg of vitamin C in crystalline form |
Timeline
- Start date
- 2021-11-26
- Primary completion
- 2022-11-26
- Completion
- 2023-11-26
- First posted
- 2022-01-11
- Last updated
- 2024-05-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05183880. Inclusion in this directory is not an endorsement.